HCW Biologics
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2929 N Commerce Pkwy, Miramar, Florida, ...Phone Number
(954) 842-2024Website
www.hcwbiologics.comRevenue
$6.7 MillionStock Symbol
HCWBIndustry
About HCW Biologics
HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for chronic inflammation-driven diseases, including autoimmune disorders, cancer, and senescence-associated dysplasia. Led by Founder/CEO Dr. Hing C. Wong (who previously developed FDA-approved Anktiva®, sold to ImmunityBio for $1.0B), lead candidates HCW9302, HCW11-018b, and HCW11-040 are in clinical/preclinical development. The company also commercializes reagents (HCW9206, HCW9201) supporting CAR-T and NK-cell therapy manufacturing.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: HCWBShow moreHCW Biologics Org Chart
Compare Similar Companies to HCW Biologics
Compare insights from companies similar to HCW Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
HCW Biologics Tech Stack
A closer look at the technologies used by HCW Biologics
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding HCW Biologics
Sign Up For FreeTo access detailed company insights
HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics for chronic inflammation-driven diseases, including autoimmune disorders, cancer, and senescence-associated dysplasia. Led by Founder/CEO Dr. Hing C. Wong (who previously developed FDA-approved Anktiva®, sold to ImmunityBio for $1.0B), lead candidates H... Read More

